Pharmacokinetic interaction study of sulphasalazine in healthy subjects and the impact of curcumin as an in vivo inhibitor of BCRP
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacokinetic interaction study of sulphasalazine in healthy subjects and the impact of curcumin as an in vivo inhibitor of BCRP
Authors
Keywords
-
Journal
BRITISH JOURNAL OF PHARMACOLOGY
Volume 166, Issue 6, Pages 1793-1803
Publisher
Wiley
Online
2012-02-02
DOI
10.1111/j.1476-5381.2012.01887.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Guide to Receptors and Channels (GRAC), 5th edition
- (2011) SPH Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- Prediction of Nonlinear Intestinal Absorption of CYP3A4 and P-Glycoprotein Substrates from their In Vitro Km Values
- (2011) Tatsuhiko Tachibana et al. PHARMACEUTICAL RESEARCH
- Fruit juice inhibition of uptake transport: a new type of food-drug interaction
- (2010) David G. Bailey BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Orange and apple juice greatly reduce the plasma concentrations of the OATP2B1 substrate aliskiren
- (2010) Tuija Tapaninen et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Membrane transporters in drug development
- (2010) NATURE REVIEWS DRUG DISCOVERY
- The effects of the SLCO2B1 c.1457C>T polymorphism and apple juice on the pharmacokinetics of fexofenadine and midazolam in humans
- (2010) Junko Imanaga et al. Pharmacogenetics and Genomics
- Influence of drug-transporter polymorphisms on the pharmacokinetics of fexofenadine enantiomers
- (2010) Yumiko Akamine et al. XENOBIOTICA
- Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting
- (2009) Arik Dahan et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Kinetic Characterization of Sulfasalazine Transport by Human ATP-Binding Cassette G2
- (2009) Márton Jani et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- ABCG2 Polymorphism Markedly Affects the Pharmacokinetics of Atorvastatin and Rosuvastatin
- (2009) J E Keskitalo et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Method for predicting the risk of drug–drug interactions involving inhibition of intestinal CYP3A4 and P-glycoprotein
- (2009) T. Tachibana et al. XENOBIOTICA
- Physiological and pharmacological roles of ABCG2 (BCRP): Recent findings in Abcg2 knockout mice
- (2008) Maria L.H. Vlaming et al. ADVANCED DRUG DELIVERY REVIEWS
- Pharmacokinetics of Curcumin Conjugate Metabolites in Healthy Human Subjects
- (2008) S. K. Vareed et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Pharmacogenetic Characterization of Sulfasalazine Disposition Based on NAT2 and ABCG2 (BCRP) Gene Polymorphisms in Humans
- (2008) Y Yamasaki et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Intestinal efflux transporters and drug absorption
- (2008) Teruo Murakami et al. Expert Opinion on Drug Metabolism & Toxicology
- Curcumin Inhibits the Activity of ABCG2/BCRP1, a Multidrug Resistance-Linked ABC Drug Transporter in Mice
- (2008) Suneet Shukla et al. PHARMACEUTICAL RESEARCH
- Pharmacogenomic importance of ABCG2
- (2008) George Cusatis et al. PHARMACOGENOMICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now